Type 2 Diabetes Patients Taking Exenatide Once Weekly, a Phase 3 Investigational Diabetes Therapy, Showed Improvements in Glycemic Contr... (port that weight loss (even a modest amo...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> TECHNOLOGY

Type 2 Diabetes Patients Taking Exenatide Once Weekly, a Phase 3 Investigational Diabetes Therapy, Showed Improvements in Glycemic Control, Weight

Date:6/7/2008

port that weight loss (even a modest amount) helps patients in their efforts to achieve and sustain glycemic control.(6,7)

Important Safety Information for BYETTA

BYETTA improves glucose (blood sugar) control in adults with type 2 diabetes. It is used with metformin, a sulfonylurea, or a thiazolidinedione. BYETTA is not a substitute for insulin in patients whose diabetes requires insulin treatment. BYETTA is not recommended for use in patients with severe problems digesting food or those who have severe disease of the stomach or kidney.

When BYETTA is used with a medicine that contains a sulfonylurea, hypoglycemia (low blood sugar) is a possible side effect. To reduce this possibility, the dose of sulfonylurea medicine may need to be reduced while using BYETTA. Other common side effects with BYETTA include nausea, vomiting, diarrhea, dizziness, headache, feeling jittery, and acid stomach. Nausea is the most common side effect when first starting BYETTA, but decreases over time in most patients.

If patients experience the following severe and persistent symptoms (alone or in combination): abdominal pain, nausea, vomiting, or diarrhea, they should talk to their healthcare provider because these symptoms could be signs of serious medical conditions. BYETTA may reduce appetite, the amount of food eaten, and body weight. No changes in dose are needed for these side effects. These are not all of the side effects from use of BYETTA. A healthcare provider should be consulted about any side effect that is bothersome or does not go away.

For full prescribing information, visit http://www.BYETTA.com.

About Amylin, Lilly and Alkermes

Amylin, Lilly, and Alkermes are working together to develop exenatide once weekly, a subcutaneous injection of exenatide for the treatment of type 2 diabetes based on Alkermes' proprietary technology for long-acting medications. Exenatide once weekly
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3 4 5 6 7 8
Related medicine technology :

1. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
2. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
3. The Heart, Diabetes, And Weight Loss Centers of New York Introduce the New Science of Metabolic Diagnosis and Weight Management
4. Isis Initiates Phase 1 Study of ISIS 325568 Targeting Glucagon Receptor to Treat Type 2 Diabetes
5. Diabetes Research Institute Invention Promotes Growth of Stem Cells into Insulin-Producing Cells
6. Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure
7. ACTOS(R) (pioglitazone HCl) Demonstrates Reduced Risk of Ischemic Cardiovascular Disease in Patients with Type 2 Diabetes
8. Nastech Pharmaceutical Company Announces Initiation of Phase 2 Clinical Trial for Insulin Nasal Spray to Treat Diabetes
9. DiObex Begins Dosing Patients in Phase 2b Trial of Type 2 Diabetes Drug
10. Synvista Therapeutics Alagebrium Shows Potential for use in Treating Diabetes-Related Gastrointestinal Complications
11. Synvista Collaboration Demonstrates in Preclinical Studies the Mechanism for Defective Cholesterol Transport in Patients with Diabetes

Post Your Comments:

(Date:8/19/2008)...n., Aug. 19 /- VION,PHARMAC... that it had,entered into an agreement with the Du... Oncology (the "HOVON") to conduct a clinical tria... standard remission-induction,therapy in patients ...nous,leukemia (AML) and high-risk myelodysplasia (...

(Date:8/18/2008)...8 /PRNewswire-USNewswire/ -- Boston University and... Center for Human Genetics, Inc.,("CHG") and Direc...versity,announced that CHG will no longer offer t...ena Diagnostics, Inc., These patented tests inclu...d to A1555G or Connexin 26 mutations, developmenta...

(Date:8/18/2008)... with Strong Clinical Research Relationships and P...ons to Lead Commercialization, SANTA CLARA, Calif...c.,(OTC Bulletin Board: NWCI) a cardiac diagnosti...nt W. Renz has joined NewCardio as its president. ...ion effort, to include,business development, clien...

(Date:8/15/2008)...Aug. 15 /- Globus Medical, Inc., the ... in the world, today announced,that the first FLEX...der an,Investigational Device Exemption ("IDE") re...and Dr. Rhett Murray., The FLEXUS(TM) Spacer is p...us processes with minimal disruption to the surrou...

Breaking Medicine Technology:Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy 2 Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy 3 Vincent W. Renz Joins NewCardio as President 2 Vincent W. Renz Joins NewCardio as President 3 Vincent W. Renz Joins NewCardio as President 4 First FLEXUS(TM) Interspinous Spacer Surgeries for IDE Clinical Trial 2 Principle of Recursive Genome Function Supersedes Dogmas 3B By Andras Pellionisz Online Ahead of Print 3B 28Scientific Visionary Vindicated 29 6587 1 Principle of Recursive Genome Function Supersedes Dogmas 3B By Andras Pellionisz Online Ahead of Print 3B 28Scientific Visionary Vindicated 29 6587 2 Principle of Recursive Genome Function Supersedes Dogmas 3B By Andras Pellionisz Online Ahead of Print 3B 28Scientific Visionary Vindicated 29 6587 3 Principle of Recursive Genome Function Supersedes Dogmas 3B By Andras Pellionisz Online Ahead of Print 3B 28Scientific Visionary Vindicated 29 6587 4 Principle of Recursive Genome Function Supersedes Dogmas 3B By Andras Pellionisz Online Ahead of Print 3B 28Scientific Visionary Vindicated 29 6587 5 Tips on how to build a better home for biological parts 4079 1 Tips on how to build a better home for biological parts 4079 2 Tips on how to build a better home for biological parts 4079 3 Concentric Named to List of Top 60 Healthcare Agencies in U S 24118 1 Concentric Named to List of Top 60 Healthcare Agencies in U S 24118 2 MDCT virtual gastroscopy and MPR images differentiate malignant and benign gastric ulcers 24114 1

[0] Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy [0] Boston University and The Center for Human Genetics, Inc. Announce Change in Testing Services [0] Vincent W. Renz Joins NewCardio as President [2] First FLEXUS(TM) Interspinous Spacer Surgeries for IDE Clinical Trial

...e than half of infertile couples willing to,donate...Md., June 20, 2007 /PRNewswire/ -- RESOLVE: The,Na...g statement,today, in anticipation of President Bu... current limitations on stem cell,research: , "Pre...fe-saving,gift the infertility community is willin...

...USINESS WIRE)--Jun 25, 2007 - Elixir,Pharmaceutica...cal,data highlighting the ability of Glufast(R) (m...ation therapy with metformin, to,manage glucose su...ed in the Abstract Book for the American Diabetes,...cago, Illinois.,Glufast is an insulin secretagogue...

Other Medicine Technology:Infertile Voice Supports Stem Cell Research: RESOLVE Calls for,Patient Options in Using Frozen Embryos 2 Elixir Pharmaceuticals Announces Clinical Data at American Diabetes,Association Conference Highlighting Ability of Glufast to Maintain,Glycemic Control in Patients with Type 2 Diabetes 2 Elixir Pharmaceuticals Announces Clinical Data at American Diabetes,Association Conference Highlighting Ability of Glufast to Maintain,Glycemic Control in Patients with Type 2 Diabetes 3 Elixir Pharmaceuticals Announces Clinical Data at American Diabetes,Association Conference Highlighting Ability of Glufast to Maintain,Glycemic Control in Patients with Type 2 Diabetes 4 Elixir Pharmaceuticals Announces Clinical Data at American Diabetes,Association Conference Highlighting Ability of Glufast to Maintain,Glycemic Control in Patients with Type 2 Diabetes 5

Infertile Voice Supports Stem Cell Research: RESOLVE Calls for,Patient Options in Using Frozen Embryos Elixir Pharmaceuticals Announces Clinical Data at American Diabetes,Association Conference Highlighting Ability of Glufast to Maintain,Glycemic Control in Patients with Type 2 Diabetes

(Date:8/20/2008)... CREEK, Calif., Aug. 20 /PRNewswire-FirstCall/ -- ...reported preliminary income from,continuing operat... $27.5,million, or $0.76 per diluted share, includ...r diluted share, related to provisions for store,c...a 6.8 percent increase,compared with income from c...

(Date:8/20/2008)...IELD, Mich., Aug. 20 /PRNewswire/ -- WXYZ- TV/Chan...lness Promotion will give thousands of,Detroit met...LTHY LIVING,FOR KIDS" program. This year the progr...m. to 5 p.m. at the Charles H. Wright Museum of Af...7, "Healthy Living for Kids",has provided free imm...

(Date:8/20/2008)...N and OTTAWA, Aug. 20 /PRNewswire-FirstCall/ -- iN...nd information portal, announced,today the third w...g a free,Nintendo Wii and Wii Fit system. The Winn...n, Michigan. iNutrition sweepstakes winner Ron Mil...excited." He then told his,son who responded with,...

(Date:8/20/2008)...PRINGS, Pa., Aug. 20 /PRNewswire-USNewswire/ -- Go... agricultural industry is struggling,with high fue...ng the need,to secure the state,s energy independe...g adults., Nearly 900 guests gathered to hear the...ay Luncheon at Ag Progress Days, Pennsylvania,s,la...

[0] Longs Drug Stores Corporation Reports Second Quarter Results [0] WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History [0] Weight Loss and Fitness Information Site iNutrition.com Gives Away Third Nintendo Wii and Wii Fit [0] Pennsylvania Governor Rendell Highlights Renewable Energy, Health Care Reform at Ag Progress Days

...lips who was on his way to becoming a lawyer says ...// “The top step had ice, and I went straight over...urs, and when they found me, I had blood coming ou... recollection for two and a half years after that ...

... their risk of birth defects. Now, new research sh...e.// Researchers say about 31,000 stroke-related d...s may have been prevented each year since fortific...s homocysteine levels. People with higher homocyst...

...esearchers say the estrogen pills do not reduce th...ed risk of stroke.// Researchers say their result...or decrease the risk of heart disease as combinati...trogen also does not appear to affect a woman’s ri...

...could help fight another. Researchers say the litt...G , may hold a key to helping researchers devise n...results from the Multicenter Acquired Immunodefici...estigators followed a large group of HIV-infected ...

Other Medicine News:

New Treatment For Headache Folic Acid Found To Be Beneficial For Stroke Patients The Side Effects Of Estrogen Therapy The Possibility Of Fighting HIV with Another Virus Questioned

... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...

Medicine Products:

Antibody Detection, RBC Antibiotic MIC/MBC Antibiotic Levels Antibiotic Level, Penicillin

Type 2 Diabetes Patients Taking Exenatide Once Weekly, a Phase 3 Investigational Diabetes Therapy, Showed Improvements in Glycemic Contr...(port that weight loss (even a modest amo...),Health